Clarus Ventures logo

Clarus Ventures

North America, Massachusetts, United States, Cambridge

Description

Clarus Ventures is a Massachusetts-based venture capital firm focused on investments in the healthcare sector.

Investor Profile

Clarus Ventures has made 86 investments, with 0 in the past 12 months and 44% as lead.

Stage Focus

  • Series B (27%)
  • Series A (22%)
  • Series Unknown (19%)
  • Series C (14%)
  • Series D (7%)
  • Private Equity (5%)
  • Series E (2%)
  • Post Ipo Equity (2%)
  • Debt Financing (1%)
  • Series F (1%)

Country Focus

  • United States (90%)
  • United Kingdom (7%)
  • Switzerland (2%)
  • Canada (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Medical Device
  • Health Diagnostics
  • Therapeutics
  • Biopharma
  • Life Science
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Clarus Ventures frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 6
Abingworth
Europe, England, United Kingdom, London
Co-Investments: 6
HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 5
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 6
SV Health Investors
North America, Massachusetts, United States, Boston
Co-Investments: 11
Domain Associates
North America, California, United States, San Diego
Co-Investments: 5
New Leaf Venture Partners
North America, New York, United States, New York
Co-Investments: 7
MedImmune Ventures
North America, Maryland, United States, Gaithersburg
Co-Investments: 6
5AM Ventures
North America, California, United States, Menlo Park
Co-Investments: 8
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 10

Which angels does Clarus Ventures often collaborate with?

Shared Deals: 1
HT
Europe, Noord-Brabant, The Netherlands, Tilburg
Shared Deals: 1
SH
North America, California, United States
Shared Deals: 1
Shared Deals: 1
GM
North America, Texas, United States, Houston
Shared Deals: 1
Shared Deals: 1
Shared Deals: 1
AP
North America, New Jersey, United States, Hackensack
Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by Clarus Ventures?

Galera Therapeutics

Malvern, Pennsylvania, United States

Galera Therapeutics develops therapeutic agents for preventing damage to normal tissues during the radiation treatment of cancer.

BiotechnologyLife ScienceTherapeutics
Series CSep 19, 2018
Amount Raised: $70,000,000
Avrobio

Cambridge, Massachusetts, United States

Avrobio is a clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease.

BiotechnologyGeneticsHealth Care
Series BFeb 1, 2018
Amount Raised: $60,000,000
Forty Seven

Palo Alto, California, United States

Forty Seven is a clinical-stage immuno-oncology company that is developing therapies targeting cancer immune evasion pathways.

BiotechnologyClinical TrialsHealth CareOncology
Series BOct 17, 2017
Amount Raised: $75,000,000
Gritstone bio

Emeryville, California, United States

Gritstone bio is a biotechnology company that develops immunotherapies for cancer and infectious diseases.

BiotechnologyHealth CareTherapeutics
Series BSep 7, 2017
Amount Raised: $93,000,000
PATH

Seattle, Washington, United States

PATH is a non-profit health organization that develops, deploys, and scales up innovations to improve health for all.

Health CareMedicalNon Profit
Series UnknownFeb 1, 2017
Amount Raised: $25,000,000
Cleave Therapeutics

San Francisco, California, United States

Cleave Therapeutics is focused on protein homeostasis and stress pathways in cancer and neurodegeneration.

BiopharmaBiotechnologyHealth Care
Series BAug 17, 2016
Amount Raised: $37,000,000
Avrobio

Cambridge, Massachusetts, United States

Avrobio is a clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease.

BiotechnologyGeneticsHealth Care
Series AAug 2, 2016
Amount Raised: $25,000,000
Annexon Biosciences

South San Francisco, California, United States

Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.

BiotechnologyHealth CareHealth DiagnosticsLife ScienceTherapeutics
Series BJun 23, 2016
Amount Raised: $44,000,000
Flowonix

Budd Lake, New Jersey, United States

Flowonix is a medical device company developing solutions for patients with chronic disorders.

Health CareMedical Device
Debt FinancingJun 2, 2016
Amount Raised: $5,000,000
GrayBug

Redwood City, California, United States

GrayBug is a biopharmaceutical company that develops transformative medicines for ocular diseases.

BiotechnologyHealth CareMedicalPharmaceutical
Series BMay 2, 2016
Amount Raised: $44,500,000